Talking Rheumatology Research

Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis


Listen Later

Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. 

Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition.

You can read this article [https://doi.org/10.1093/rheumatology/kead604] in Rheumatology.

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

...more
View all episodesView all episodes
Download on the App Store

Talking Rheumatology ResearchBy British Society for Rheumatology

  • 5
  • 5
  • 5
  • 5
  • 5

5

1 ratings


More shows like Talking Rheumatology Research

View all
Rheumnow Podcast by Dr. Cush

Rheumnow Podcast

124 Listeners

The Evidence Based Rheumatology Podcast by Michael Putman

The Evidence Based Rheumatology Podcast

114 Listeners

ACR on Air by American College of Rheumatology

ACR on Air

71 Listeners

The Rest Is History by Goalhanger

The Rest Is History

13,446 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,083 Listeners

Talking Rheumatology Spotlight by British Society for Rheumatology

Talking Rheumatology Spotlight

6 Listeners

ACR Journals On Air by American College of Rheumatology

ACR Journals On Air

20 Listeners